Excellos

Excellos provides a comprehensive range of services as a Contract Development and Manufacturing Organization (CDMO). Our offerings include cGMP manufacturing of cell and gene therapies, development services for process optimization, analytical testing, and regulatory support. We specialize in the collection of critical human cells and tissues, ensuring that our clients receive high-quality materials for their therapeutic applications.

At Excellos, we adhere to stringent current Good Manufacturing Practices (cGMP) to ensure the highest quality and safety of our products. Our facilities are designed to meet regulatory standards, and our processes are regularly audited to maintain compliance. We also have a dedicated quality assurance team that oversees all manufacturing and development activities, ensuring that every step meets both internal and external regulatory requirements.

Excellos primarily supports the biopharmaceutical industry, focusing on companies involved in cell and gene therapy development. Our clients range from startups to established pharmaceutical companies looking to innovate in regenerative medicine, oncology, and rare diseases. We also collaborate with academic institutions and research organizations to advance therapeutic solutions.

Yes, Excellos specializes in the development of custom cell and gene therapies tailored to meet the specific needs of our clients. We work closely with our partners to understand their unique requirements and provide tailored solutions throughout the development process, from initial concept through to clinical manufacturing. Our experienced team is equipped to handle various types of therapies, including CAR-T cells, stem cells, and gene-modified cells.

To partner with Excellos for manufacturing services, interested clients can reach out through our website or contact our business development team directly. We begin with an initial consultation to understand your project requirements and goals. After assessing your needs, we will provide a detailed proposal outlining our capabilities, timelines, and costs. Once both parties agree on the terms, we will initiate the project and work collaboratively throughout the manufacturing process.

Yes, Excellos provides comprehensive support for regulatory submissions related to cell and gene therapies. Our team is well-versed in the regulatory landscape and can assist clients in preparing the necessary documentation for submissions to regulatory agencies such as the FDA and EMA. We offer guidance on best practices for compliance and can help navigate the complexities of the approval process to facilitate a smoother path to market.